Related Experiment Video
Updated: Feb 11, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Zebularine exerts its antiproliferative activity through S phase delay and cell death in human malignant mesothelioma
Yukitoshi Takemura1, Motohiko Satoh1, Kenichi Hatanaka1
1a Institute of Industrial Science , The University of Tokyo , Tokyo , Japan.
Abstract:
Malignant mesothelioma is an asbestos-related aggressive tumor and current therapy remains ineffective. Zebularine as a DNA methyltransferase (DNMT) inhibitor has an anti-tumor effect in several human cancer cells. The aim of the present study was to investigate whether zebularine could induce antiproliferative effect in human malignant mesothelioma cells. Zebularine induced cell growth inhibition in a dose-dependent manner. In addition, zebularine dose-dependently decreased expression of DNMT1 in all malignant mesothelioma cells tested. Cell cycle analysis indicated that zebularine induced S phase delay. Zebularine also induced cell death in malignant mesothelioma cells. In contrast, zebularine did not induce cell growth inhibition and cell death in human normal fibroblast cells. These results suggest that zebularine has a potential for the treatment of malignant mesothelioma by inhibiting cell growth and inducing cell death.
Insights
Zebularine, a DNA methyltransferase inhibitor, shows potential against malignant mesothelioma. It effectively inhibits cancer cell growth and induces cell death without harming normal cells.
Area of Science:
- Oncology
- Cancer Biology
- Pharmacology
Background:
- Malignant mesothelioma is an aggressive asbestos-related cancer with limited treatment options.
- DNA methyltransferase (DNMT) inhibitors, like zebularine, have demonstrated anti-tumor effects in various cancers.
- The efficacy of zebularine in treating malignant mesothelioma is not well-established.
Purpose of the Study:
- To investigate the antiproliferative and cell death-inducing effects of zebularine in human malignant mesothelioma cells.
- To determine the impact of zebularine on DNA methyltransferase 1 (DNMT1) expression in mesothelioma cells.
- To assess the selectivity of zebularine's effects on cancer cells versus normal cells.
Main Methods:
- Treatment of human malignant mesothelioma cells and normal fibroblast cells with varying doses of zebularine.
- Assessment of cell growth inhibition using dose-dependent assays.
- Analysis of DNA methyltransferase 1 (DNMT1) expression levels.
- Cell cycle analysis to identify effects on cell proliferation.
- Evaluation of zebularine-induced cell death.
Main Results:
- Zebularine significantly inhibited malignant mesothelioma cell growth in a dose-dependent manner.
- Zebularine decreased the expression of DNMT1 in a dose-dependent manner across tested mesothelioma cell lines.
- Cell cycle analysis revealed that zebularine induced an S phase delay.
- Zebularine treatment resulted in cell death in malignant mesothelioma cells.
- Normal human fibroblast cells showed no significant growth inhibition or cell death upon zebularine treatment.
Conclusions:
- Zebularine exhibits potent antiproliferative and pro-death effects specifically in malignant mesothelioma cells.
- The drug's mechanism involves the inhibition of DNMT1 and induction of S phase delay.
- Zebularine demonstrates a promising therapeutic potential for malignant mesothelioma treatment due to its targeted action.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Phase Transitions
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Phase Transitions: Sublimation and Deposition
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

